General
Markers
General biomarkers are widely used in clinical practice to support the assessment of nutritional, metabolic, neurological, and glycemic status. Markers such as vitamin D, ferritin, S100B, and HbA1c provide valuable information related to bone metabolism, iron storage, neurological injury, and long-term glucose control. Altered biomarker levels may be associated with conditions including vitamin deficiencies, anemia, diabetes, and neurological disorders. By measuring general biomarker concentrations, KSB assays support the evaluation, screening, monitoring, and management of a broad range of clinical conditions.
Hemoglobin A1c (HbA1c) is an important biomarker used in the evaluation and long-term monitoring of glucose metabolism. It reflects the average blood glucose concentration over the previous two to three months and is widely applied in the screening, diagnosis support, and management of diabetes mellitus. HbA1c testing plays a key role in assessing glycemic control and monitoring therapeutic effectiveness, supporting clinicians in the prevention and management of diabetes-related complications.
Vitamin D is an essential nutrient involved in calcium and phosphorus metabolism, bone health, immune regulation, and multiple physiological processes throughout the body. Abnormal vitamin D levels may be associated with bone disorders, metabolic conditions, immune dysfunction, and other health-related complications. Measurement of vitamin D concentrations supports the evaluation of nutritional and metabolic status, assisting clinicians in deficiency screening, treatment monitoring, and overall patient health assessment.
S100 β is a calcium-binding protein primarily expressed in astrocytes and other cells of the central nervous system, serving as a clinically relevant biomarker associated with neurological injury and brain tissue damage. Elevated S100 β concentrations may be observed in conditions such as traumatic brain injury, stroke, neuroinflammation, and other neurological disorders. Measurement of S100 β levels supports the clinical assessment and monitoring of neurological conditions, providing valuable information regarding tissue injury and patient status.
Explore
Your
Options
深圳市康生保
生物技术有限公司
深圳市宝安区
福海 街道
新和 社区 安达
电子厂区3栋2楼
518103
+86 0755 27417763
info@ksbbiotech.com